MAPS'' mission is (1) to treat conditions for which conventional
medicines provide limited relief—such as posttraumatic stress disorder
(PTSD), pain, drug dependence, anxiety and depression associated with
end-of-life issues—by developing psychedelics and marijuana into
prescription medicines; (2) to treat many thousands of people by building
a network of clinics where treatments can be provided; and (3) to
educate the public honestly about the risks and benefits of
psychedelics and marijuana.
Multidisciplinary Association For Psychedelic Studies has not yet started any petitions.